IQVIA Holdings Inc
IQV185.860USD
-5.680-2.97%
Cierre 07/31, 16:00（ET）Cotizaciones retrasadas 15 min
31.60BCap. mercado
23.69P/E TTM
Más Datos de IQVIA Holdings Inc Compañía
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Información de la empresa
Símbolo de cotizaciónIQV
Nombre de la empresaIQVIA Holdings Inc
Fecha de salida a bolsaMay 09, 2013
Fundada en2016
Director ejecutivoMr. Ari Bousbib
Número de empleados88000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 09
Dirección2400 Ellis Road
CiudadDURHAM
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal27703
Teléfono19199982000
Sitio Webhttps://ir.iqvia.com/
Símbolo de cotizaciónIQV
Fecha de salida a bolsaMay 09, 2013
Fundada en2016
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
7.01K
+17.56%
Mr. James A. Fasano
Mr. James A. Fasano
Independent Director
Independent Director
2.74K
+157.67%
Mr. John P. Connaughton
Mr. John P. Connaughton
Independent Director
Independent Director
1.05K
--
Mr. Bhavik Patel
Mr. Bhavik Patel
President, Commercial Solutions
President, Commercial Solutions
863.00
-8.87%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ari Bousbib
Mr. Ari Bousbib
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.35M
+0.75%
Mr. Ronald E. (Ron) Bruehlman
Mr. Ronald E. (Ron) Bruehlman
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
46.46K
-1.91%
Mr. John G. Danhakl
Mr. John G. Danhakl
Independent Director
Independent Director
30.85K
-79.16%
Mr. Eric M. Sherbet
Mr. Eric M. Sherbet
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
21.11K
--
Ms. Colleen A. Goggins
Ms. Colleen A. Goggins
Independent Director
Independent Director
16.83K
+10.45%
Dr. John M. Leonard, M.D.
Dr. John M. Leonard, M.D.
Lead Independent Director
Lead Independent Director
15.38K
+11.55%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Americas
1.81B
47.19%
Europe & Africa Region
1.22B
31.97%
Asia Pacific Region
798.00M
20.84%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: jue., 24 de jul
Actualizado: jue., 24 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.62%
Harris Associates L.P.
6.57%
BlackRock Institutional Trust Company, N.A.
5.81%
State Street Global Advisors (US)
4.54%
GIC Private Limited
3.85%
Other
67.60%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.62%
Harris Associates L.P.
6.57%
BlackRock Institutional Trust Company, N.A.
5.81%
State Street Global Advisors (US)
4.54%
GIC Private Limited
3.85%
Other
67.60%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
45.68%
Investment Advisor/Hedge Fund
31.75%
Hedge Fund
6.56%
Sovereign Wealth Fund
4.94%
Pension Fund
4.66%
Research Firm
2.37%
Bank and Trust
2.16%
Individual Investor
0.91%
Family Office
0.10%
Other
0.88%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
2044
168.82M
99.30%
-7.45M
2025Q1
2083
168.53M
97.38%
-9.36M
2024Q4
2059
171.87M
97.45%
+3.00M
2024Q3
2008
173.01M
95.44%
+863.78K
2024Q2
1977
164.85M
90.43%
-7.68M
2024Q1
1950
165.50M
90.84%
-10.38M
2023Q4
1948
168.90M
93.03%
-6.38M
2023Q3
1925
170.01M
92.82%
-4.41M
2023Q2
1898
167.84M
91.62%
-8.26M
2023Q1
1870
169.28M
91.24%
-7.20M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
19.76M
11.42%
-293.38K
-1.46%
Mar 31, 2025
Harris Associates L.P.
11.17M
6.46%
-166.29K
-1.47%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
9.88M
5.71%
-196.58K
-1.95%
Mar 31, 2025
State Street Global Advisors (US)
7.72M
4.46%
-157.55K
-2.00%
Mar 31, 2025
GIC Private Limited
6.54M
3.78%
-2.59M
-28.36%
Mar 31, 2025
CPP Investment Board
4.59M
2.66%
+312.81K
+7.31%
Mar 31, 2025
Geode Capital Management, L.L.C.
4.24M
2.45%
+59.53K
+1.43%
Mar 31, 2025
AllianceBernstein L.P.
3.54M
2.04%
-57.68K
-1.60%
Mar 31, 2025
Farallon Capital Management, L.L.C.
3.41M
1.97%
+288.70K
+9.24%
Mar 31, 2025
Capital Research Global Investors
2.13M
1.23%
+589.82K
+38.40%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: dom., 6 de jul
Actualizado: dom., 6 de jul
Nombre
Proporción
First Trust Nasdaq Lux Digi Health Solutions ETF
6.05%
VanEck Biotech ETF
3.83%
Global X HealthTech ETF
3.58%
Langar Global HealthTech ETF
2.7%
iShares Biotechnology ETF
2.58%
American Century Focused Large Cap Value ETF
2.11%
American Century Mid Cap Growth Impact ETF
2.05%
Running Oak Efficient Growth ETF
1.7%
Invesco Zacks Mid-Cap ETF
1.59%
Fidelity Digital Health ETF
1.52%
Ver más
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción6.05%
VanEck Biotech ETF
Proporción3.83%
Global X HealthTech ETF
Proporción3.58%
Langar Global HealthTech ETF
Proporción2.7%
iShares Biotechnology ETF
Proporción2.58%
American Century Focused Large Cap Value ETF
Proporción2.11%
American Century Mid Cap Growth Impact ETF
Proporción2.05%
Running Oak Efficient Growth ETF
Proporción1.7%
Invesco Zacks Mid-Cap ETF
Proporción1.59%
Fidelity Digital Health ETF
Proporción1.52%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
